Engineering Platelets for Combined Anticancer Therapy

Tumor targeting and intratumoral penetration are long-standing issues for cancer therapeutics.In a recent study published inScience Advanceson March 26,researchers from the CAS Institute of Process Engineering(IPE)and the University of Chinese Academy of Sciences(UCAS)have developed a new platelet-based formulation which demonstrated potent therapeutic effects against cancer in murine models.